SD-ART
BehavioralSD-ART protocol for PWH with both patients and their HIV clinicians
NCT Number: NCT07053514
The goal of this study is to develop and implement a same-day ART (SD-ART) protocol for key affected populations with HIV in Peru. The development of the protocol will be guided by asynchronous online focus groups with HIV experts to define eligibility criteria and essential components of the protocol, as well as nominal group technique focus groups and in-depth interviews to identify barriers and facilitators to SD-ART implementation. Finally, investigators will pilot the SD-ART protocol with patients and clinicians using a prospective, longitudinal design integrated into routine HIV care.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Centro de Salud Raul Patrucco Puig, Lima, Peru
The proposed study has 3 aims:
The focus of this registration is the trial in aim 3.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
HIV experts will be selected from National Societies of HIV experts according to the following criteria: 1) 18 years old or older; 2) Be an HIV expert, including those from NGOs providing HIV care, and international specialists; 3) Provide informed consent.
SD-ART protocol for PWH with both patients and their HIV clinicians
Time frame: baseline, month 1, month 3, month 6, month 9, and month 12
Assessed using a modified 10-item version of the Berger HIV stigma scale, which has been previously translated into Spanish and validated in Peru. Total score range from 40 to 160. Higher scores denote higher levels of HIV stigma.
Time frame: baseline, month 1, month 3, month 6, month 9, and month 12
Measured through feeling thermometers (on a scale from 0-100) of various identity groups (people with HIV, sexual minorities, people who use drugs).
Time frame: baseline, month 1, month 3, month 6, month 9, and month 12
This is a 5-item scale that is rated on a 6-point scale (range from 0 to 30), with higher scores denoting higher levels of multi-dimensional stigma and experiences with discrimination
Contact information is provided by the study sponsor or research team.
Yale University
Other
Acronym: Peru SD-ART
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06015581
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Tallahassee, Florida, United States
View Trial DetailsNCT07647432
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
View Trial DetailsNCT06805656
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
São Paulo, Brazil
View Trial DetailsNCT07579247
AIDS, Acquired Immunodeficiency Syndrome
Shanghai, Shanghai Municipality, China
View Trial Details